Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Multidrug resistance in chronic lymphocytic leukemia
Download
093423.pdf
Date
2000
Author
Şimşek, Senem
Metadata
Show full item record
Item Usage Stats
221
views
0
downloads
Cite This
URI
https://hdl.handle.net/11511/7629
Collections
Graduate School of Natural and Applied Sciences, Thesis
Suggestions
OpenMETU
Core
Multidrug resistance in locally advanced breast cancer
Atalay, Can; Gurhan, Ismet Deliloglu; Irkkan, Cigdem; Gündüz, Ufuk (2006-01-01)
Background: Advanced breast cancer cases can still be encountered resulting in poor prognosis. The primary treatment for these patients is chemotherapy, and multidrug resistance (MDR) is a serious obstacle in the treatment. Detecting drug resistance before first-line chemotherapy may increase the patient's survival. In this study, the role of MDR is evaluated in locally advanced breast cancer patients. Methods: Reverse transcriptase polymerase chain reaction was used for the detection of MDR genes, ABCB1 an...
Multidrug resistance in logally advanced breast cancer
Atalay, Mustafa Can; Gündüz, Ufuk; Department of Biotechnology (2004)
Breast cancer is the most frequently detected cancer among women. Early diagnosis leads to long term survival when the patients are treated with surgery, radiotherapy, chemotherapy, and hormone therapy. Unfortunately, advanced disease could still be encountered in some patients resulting in a poorer prognosis. The primary treatment modality is chemotherapy for this group of patients. Drug resistance is a serious problem resulting in the use of different drugs during chemotherapy and knowing the possibility ...
Multidrug Resistance Mediated by MRP1 Gene Overexpression in Breast Cancer Patients
Abaan, Ogan Demir; Mutlu, Pelin; Baran, Yusuf; Atalay, Can; Gündüz, Ufuk (2009-01-01)
Multidrug resistance (MDR) is a serious handicap towards the effective treatment of breast cancer patients. One of the most prevalent MDR mechanisms is through the overexpression of genes coding the proteins called Multidrug Resistance-associated Proteins (MRPs). The aim of this study was to investigate the expression of MRP1 in tumor tissues from breast cancer patients. In this study, a semi-quantitative RT-PCR approach was utilized. Our results suggest that MRP1 overexpression can mediate MDR in patients....
Multidrug resistance mechanisms in imatinib resistant human chronic myeloid leukemia cells
Baran, Yusuf; Gündüz, Ufuk; Department of Biology (2006)
In this study, mechanisms of resistance to Imatinib-induced apoptosis in human K562 and Meg-1 chronic myeloid leukemia (CML) cells were examined. Continuous exposure of cells to step-wise increasing concentrations of Imatinib resulted in the selection of 0.2 and 1 ́M İmatinib resistant cells. Measurement of endogenous ceramide levels showed that treatment with Imatinib increased the generation of C18-ceramide significantly, which is mainly synthesized by the human longevity assurance gene 1 (hLASS1), in sen...
Multidrug Resistant Clones of Salmonella Infantis from Broiler Chickens
Bulut, Ece; Acar, Sinem; Durul, Bora; Aydin, Sacide O; Soyer, Yeşim (2015-07-28)
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
S. Şimşek, “Multidrug resistance in chronic lymphocytic leukemia,” Middle East Technical University, 2000.